(Q38020728)

27 August 2017

title

The role of inflammation and proteinases in tumor progression (English)

1 reference

27 August 2017

1 reference

0 references

László Herszényi

1

1 reference

27 August 2017

Gábor Lakatos

2

1 reference

27 August 2017

István Hritz

3

1 reference

27 August 2017

Mária Zsófia Varga

4

1 reference

27 August 2017

Gabriel Cierny

5

1 reference

27 August 2017

Zsolt Tulassay

6

1 reference

27 August 2017

language of work or name

1 reference

20 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

249-254

1 reference

Inflammation and cancer: back to Virchow?

27 August 2017

cites work

1 reference

21 January 2018

Inflammation and cancer

1 reference

Cancer-related inflammation

21 January 2018

1 reference

Genetic aspects of inflammation and cancer

21 January 2018

1 reference

Infections as a major preventable cause of human cancer

21 January 2018

1 reference

Molecular pathways and targets in cancer-related inflammation

21 January 2018

1 reference

Inflammatory bowel disease as a risk factor for colorectal cancer.

21 January 2018

1 reference

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease

21 January 2018

1 reference

Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.

21 January 2018

1 reference

21 January 2018

1 reference

Inflammation and immunity in the tumor environment

21 January 2018

1 reference

Interplay of natural killer cells and their receptors with the adaptive immune response

21 January 2018

1 reference

Dendritic cell interactions with NK cells from different tissues

21 January 2018

1 reference

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

21 January 2018

1 reference

Inflammation and cancer: IL-6 and STAT3 complete the link.

21 January 2018

1 reference

Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?

21 January 2018

1 reference

Targeting cell spreading: a method of sensitizing metastatic tumor cells to TRAIL-induced apoptosis

21 January 2018

1 reference

Oxidative stress and inducible nitric oxide synthase induction in carcinogenesis

21 January 2018

1 reference

Oxidative stress and oxidative damage in carcinogenesis

21 January 2018

1 reference

Oxidative stress, DNA methylation and carcinogenesis.

21 January 2018

1 reference

Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.

21 January 2018

1 reference

Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue

21 January 2018

1 reference

Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies

21 January 2018

1 reference

Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals

21 January 2018

1 reference

Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer

21 January 2018

1 reference

Current concepts in metastasis

21 January 2018

1 reference

Proteases in gastrointestinal neoplastic diseases

21 January 2018

1 reference

Molecular mechanisms of metastasis.

21 January 2018

1 reference

Lymphangiogenesis and hemangiogenesis: potential targets for therapy

21 January 2018

1 reference

Proteases, extracellular matrix, and cancer: a workshop of the path B study section

21 January 2018

1 reference

Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation

21 January 2018

1 reference

The microenvironment of the tumour-host interface

21 January 2018

1 reference

Physiological mechanisms of tumor-cell invasion and migration

21 January 2018

1 reference

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

21 January 2018

1 reference

Inflammation, proteases and cancer

21 January 2018

1 reference

Delineating protease functions during cancer development

21 January 2018

1 reference

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

21 January 2018

1 reference

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states

21 January 2018

1 reference

Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells

21 January 2018

1 reference

Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis

21 January 2018

1 reference

Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.

21 January 2018

1 reference

Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome

21 January 2018

1 reference

Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease

21 January 2018

1 reference

Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis

21 January 2018

1 reference

Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease

21 January 2018

1 reference

Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?

21 January 2018

1 reference

The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.

21 January 2018

1 reference

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

21 January 2018

1 reference

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

21 January 2018

1 reference

Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers

21 January 2018

1 reference

Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression

21 January 2018

1 reference

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator

21 January 2018

1 reference

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α.

21 January 2018

1 reference

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

21 January 2018

1 reference

MMPs as therapeutic targets--still a viable option?

21 January 2018

1 reference

Matrix metalloproteinase inhibitors as anticancer agents

21 January 2018

1 reference

Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs).

21 January 2018

1 reference

Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.

21 January 2018

1 reference

Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000336914

1 reference

27 August 2017

1 reference